← Insider Monitor
Pelthos Therapeutics Inc. logo
PTHS

Pelthos Therapeutics Inc.

NYSE · Biological Products, (No Diagnostic Substances)

3
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

Pelthos Therapeutics is a commercial-stage pharmaceutical company focused on developing and marketing treatments in dermatology, including products for conditions such as excessive sweating. The company is headquartered in Durham, North Carolina.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Durham, NC
Exchange
NYSE

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Greenleaf PeterDirectorSell$17KOct 2, 2026
Pauls MatthewDirectorSell$17KOct 2, 2026
Friedberg Ezra MDirectorSell$12KOct 2, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for PTHS.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable PTHS activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. Outside US/Canada, include + and your country code.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.